Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
14.22
-0.02 (-0.11%)
At close: Oct 2, 2026, 4:00 PM EDT
14.27
+0.05 (0.39%)
After-hours: Oct 2, 2026, 7:59 PM EDT
Iovance Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $14 → $18 | Buy | Maintains | $14 → $18 | +26.63% | Sep 30, 2026 |
| Barclays | Barclays | Buy Maintains $15 | Buy | Maintains | $15 | +5.52% | Sep 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $9 → $20 | Buy | Reiterates | $9 → $20 | +40.70% | Sep 29, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $10 → $16 | Buy | Maintains | $10 → $16 | +12.56% | Sep 29, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $15 | Buy | Initiates | $15 | +5.52% | Sep 24, 2026 |
| UBS | UBS | Hold Reiterates $4 → $7 | Hold | Reiterates | $4 → $7 | -50.76% | Aug 20, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | -22.62% | Aug 17, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $4 → $6 | Hold | Maintains | $4 → $6 | -57.79% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.